Newsletter | April 6, 2021

04.06.21 -- AI-Generated Proteins Will Speed Up Drug Development

Industry Insights
In Vitro Test Methodologies To Characterize Bioavailability Enhancing Formulations

Some of the most important technologies available to formulators are those that enhance bioavailability, given the large percentage of low-solubility compounds in today’s pharmaceutical pipelines. Formulators have many choices in their toolkit when it comes to bioavailability enhancement, so the tough call becomes which one to use for a given compound. Lonza has developed a full complement of tools that accurately predict the performance of bioavailability-enhanced formulations.

End Of End Point Assays: SPR Analytics In Vaccine Design, Development

Discover how SPR can be used to accelerate vaccine discovery and development by helping overcome analytical challenges that have plagued the industry for decades.

Key Concepts Driving The Future Of Single-Use In Biopharma Production

This article discusses four topics related to single-use bioprocessing which are commonly cited by end users as amenable to future development. 

Using Spray Drying To Manufacture Formulations For Local Lung Cancer Treatment

On April 8, 2021, join Lonza Pharma & Biotech as they discuss how spray drying can be used to address many of the challenges associated with today’s late-stage lung cancer treatments.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.